DongKook Pharmaceutical Co. Ltd (086450.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7086450004
DongKook Pharmaceutical Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 812.17 bn KRW | 926.88 bn KRW |
| Gross profit | 447.90 bn KRW | 501.60 bn KRW |
| Operating income | 80.42 bn KRW | 96.55 bn KRW |
| EBIT | 89.24 bn KRW | 94.67 bn KRW |
| Net income | 61.22 bn KRW | 66.02 bn KRW |
| Diluted EPS – continuing operations | 1,392.34 KRW | 1,487.21 KRW |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DongKook Pharmaceutical Co. Ltd
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections. The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines. In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage. DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
More stocks
- Banco Actinver S.A. Institución de Banca Múltiple Grupo Financiero Actinver (FNOVA17.MX)
- Jiangmen iDear-Hanyu Electrical Joint-Stock Co Ltd (300403.SZ)
- Ferrari Group PLC (FERGR.AS)
- Chief Telecom Inc (6561.TWO)
- WHA Utilities and Power Public Company Limited (WHAUP.BK)
- Omnijoi Media Corp (300528.SZ)
- FBD Holdings PLC (EG7.IR)
- Pharming Group NV (PHARM.AS)
- SNP Schneider-Neureither & Partner (SHF.DE)
- Cadillac Mines Corporation (CADY.TO)
- Schaltbau Holding (SLT.HM)
- SOUTHERN MISSOURI BANCORP, INC. (SMBC)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.